연구동향 분석

헬리코박터 제균 치료의 미래

이주엽 ( Ju Yup Lee ) 김나영 ( Na Young Kim ) 2014년

논문상세정보
인용/피인용
' 헬리코박터 제균 치료의 미래' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • guidelines
  • helicobacter pylori
  • prevention
  • treatment
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
971 1

0.0%

' 헬리코박터 제균 치료의 미래' 의 참고문헌

  • 헬리코박터 파일로리 감염의 진단 및 치료 가이드라인
    김나영 대한소화기학회지 54 (5) : 269 ~ 278 [2009]
  • 한국인 환자에서 분리한 Helicobacter pylori 균주의 항생제 내성률
    김정목 대한소화기학회지 47 (5) : 337 ~ 349 [2006]
  • 한국인 헬리코박터 파일로리 감염의 진단과 치료 임상 진료지침 개정안 2013
    김상균 대한소화기학회지 62 (1) : 3 ~ 26 [2013]
  • 한국에서 지역에 따른 Helicobacter pylori 균주 내성
    김재연 대한소화기학회지 57 (4) : 221 ~ 229 [2011]
  • Worldwide H. pylori antibiotic resistance: a systematic review
    De Francesco V J Gastrointestin Liver Dis 19 : 409 ~ 414 [2010]
  • World Gastroenterology Organisation global guideline: Helicobacter pylori in developing countries
    J Dig Dis 12 : 319 ~ 326 [2011]
  • Water source as risk factor for Helicobacter pylori infection in Peruvian children
    Klein PD Lancet 337 : 1503 ~ 1506 [1991]
  • Universal high-level primary metronidazole resistance in Helicobacter pylori isolated from children in Egypt
    Sherif M J Clin Microbiol 42 : 4832 ~ 4834 [2004]
  • Type 2 diabetes mellitus affects eradication rate of Helicobacter pylori
    Sargýn M World J Gastroenterol 9 : 1126 ~ 1128 [2003]
  • Treatment for H. pylori infection: new challenges with antimicrobial resistance
    Vakil N J Clin Gastroenterol 47 : 383 ~ 388 [2013]
  • The effect of CYP2C19 polymorphisms on H. pylori eradication rate in dual and triple first-line PPI therapies: a meta-analysis
    Padol S Am J Gastroenterol 101 : 1467 ~ 1475 [2006]
  • The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention
    Lee YC Gut 62 : 676 ~ 682 [2013]
  • The Influence of CYP2C19 Polymorphism on Eradication of Helicobacter pylori: A Prospective Randomized Study of Lansoprazole and Rabeprazole
    Jeong Hoon Lee Gut and Liver 4 (2) : 201 ~ 206 [2010]
  • Ten-year prospective follow-up of histological changes at five points on the gastric mucosa as recommended by the updated Sydney system after Helicobacter pylori eradication
    Kodama M J Gastroenterol 47 : 394 ~ 403 [2012]
  • Ten-day sequential versus triple therapy for Helicobacter pylori eradication: a prospective, open-label, randomized trial
    Chung JW J Gastroenterol Hepatol 27 : 1675 ~ 1680 [2012]
  • Ten-day sequential therapy is more effective than proton pump inhibitor-based therapy in Korea: a prospective, randomized study
    Oh HS J Gastroenterol Hepatol 27 : 504 ~ 509 [2012]
  • Ten and eight-day sequential therapy in comparison to standard triple therapy for eradicating Helicobacter pylori infection: a randomized controlled study on efficacy and tolerability
    Paoluzi OA J Clin Gastroenterol 44 : 261 ~ 266 [2010]
  • Study Group participants. Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption
    Megraud F Gut 62 : 34 ~ 42 [2013]
  • Strategy for eliminating gastric cancer in Japan
    Asaka M. Helicobacter 15 : 486 ~ 490 [2010]
  • Smoking increases the treatment failure for Helicobacter pylori eradication
    Suzuki T Am J Med 119 : 217 ~ 224 [2006]
  • Seroprevalence of Helicobacter pylori in South Korea
    Yim JY Helicobacter 12 : 333 ~ 340 [2007]
  • Seroepidemiological study of Helicobacter pylori infection in asymptomatic people in South Korea
    Kim JH J Gastroenterol Hepatol 16 : 969 ~ 975 [2001]
  • Sequential therapy vs. standard triple therapies for Helicobacter pylori infection: a meta-analysis
    Tong JL J Clin Pharm Ther 34 : 41 ~ 53 [2009]
  • Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized trial
    Vaira D Ann Intern Med 146 : 556 ~ 563 [2007]
  • Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children
    Gatta L Am J Gastroenterol 104 : 3069 ~ 3079 [2009]
  • Sequential Therapy for Helicobacter pylori Infection in Korea: Systematic Review and Meta-Analysis
    김준성 Gut and Liver 7 (5) : 546 ~ 551 [2013]
  • Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection
    Fock KM J Gastroenterol Hepatol 24 : 1587 ~ 1600 [2009]
  • Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori
    Gisbert JP Aliment Pharmacol Ther 34 : 604 ~ 617 [2011]
  • Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection
    Lam SK J Gastroenterol Hepatol 13 : 1 ~ 12 [1998]
  • Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population
    Asaka M. Gastroenterology 102 : 760 ~ 766 [1992]
  • Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection
    Bayerdörffer E Lancet 345 : 1591 ~ 1594 [1995]
  • Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence
    Graham DY Clin Gastroenterol Hepatol 12 : 177 ~ 186 [2014]
  • Randomised clinical trial comparing sequential and concomitant therapies for Helicobacter pylori eradication in routine clinical practice
    McNicholl AG Gut 63 : 244 ~ 249 [2014]
  • Proton pump inhibitor-amoxicillin-clarithromycin versus proton pump inhibitor-amoxicillin-metronidazole as first-line Helicobacter pylori eradication therapy
    Nishizawa T J Clin Biochem Nutr 51 : 114 ~ 116 [2012]
  • Primary resistance in Helicobacter pylori isolated in children from Iran
    Rafeey M J Infect Chemother 13 : 291 ~ 295 [2007]
  • Primary levofloxacin resistance and gyrA/B mutations among Helicobacter pylori in Japan
    Miyachi H Helicobacter 11 : 243 ~ 249 [2006]
  • Primary antibiotic resistance in Helicobacter pylori strains isolated in northern and central Italy
    Zullo A Aliment Pharmacol Ther 25 : 1429 ~ 1434 [2007]
  • Primary and secondary antibiotic resistance of Helicobacter pylori strains isolated in central Italy during the years 1998-2002
    Toracchio S Dig Liver Dis 35 : 541 ~ 545 [2003]
  • Prevention of gastric cancer by Helicobacter pylori eradication
    Asaka M. Intern Med 49 : 633 ~ 636 [2010]
  • Prevalence of primary and secondary antimicrobial resistance of Helicobacter pylori in Korea from 2003 through 2012
    Lee JW Helicobacter 18 : 206 ~ 214 [2013]
  • Prevalence of multidrug-resistant Helicobacter pylori in Bulgaria
    Boyanova L J Med Microbiol 58 : 930 ~ 935 [2009]
  • Prevalence of Helicobacter pylori infection and identification of risk factors in rural and urban Beijing, China
    Cheng H Helicobacter 14 : 128 ~ 133 [2009]
  • Prevalence of Helicobacter (formerly Campylobacter) pylori infection in Saudia Arabia, and comparison of those with and without upper gastrointestinal symptoms
    al-Moagel MA Am J Gastroenterol 85 : 944 ~ 948 [1990]
  • Prevalence and risk factors of Helicobacter pylori infection in Korea: nationwide multicenter study over 13 years
    Lim SH BMC Gastroenterol 13 : 104 ~ [2013]
  • Prevalence and risk factors for Helicobacter pylori infection in Chinese populations
    Shi R Helicobacter 13 : 157 ~ 165 [2008]
  • Predictors of failure of Helicobacter pylori eradication with the standard 'Maastricht triple therapy'
    Perri F Aliment Pharmacol Ther 15 : 1023 ~ 1029 [2001]
  • Population-based strategies for Helicobacter pylori-associated disease management: a Japanese perspective
    Shiota S Expert Rev Gastroenterol Hepatol 4 : 149 ~ 156 [2010]
  • Pharmacogenomics-based tailored versus standard therapeutic regimen for eradication of H. pylori
    Furuta T Clin Pharmacol Ther 81 : 521 ~ 528 [2007]
  • Pharmacogenetics of the proton pump inhibitors: a systematic review
    Chong E Pharmacotherapy 23 : 460 ~ 471 [2003]
  • Optimized nonbismuth quadruple therapies cure most patients with Helicobacter pylori infection in populations with high rates of antibiotic resistance
    Molina-Infante J Gastroenterology 145 : 121 ~ 128 [2013]
  • One-week triple therapy using omeprazole, amoxycillin and clarithromycin for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia: influence of dosage of omeprazole and clarithromycin
    Bigard MA Aliment Pharmacol Ther 12 : 383 ~ 388 [1998]
  • NIH Consensus development panel on Helicobacter pylori in peptic ulcer disease
  • Most Helicobacter pylori strains of Kolkata in India are resistant to metronidazole but susceptible to other drugs commonly used for eradication and ulcer therapy
    Datta S Aliment Pharmacol Ther 22 : 51 ~ 57 [2005]
  • Modified sequential Helicobacter pylori therapy: proton pump inhibitor and amoxicillin for 14 days with clarithromycin and metronidazole added as a quadruple (hybrid) therapy for the final 7 days
    Hsu PI Helicobacter 16 : 139 ~ 145 [2011]
  • Meta-analysis: the efficacy, adverse events, and adherence related to first-line anti- Helicobacter pylori quadruple therapies
    Fischbach LA Aliment Pharmacol Ther 20 : 1071 ~ 1082 [2004]
  • Meta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment
    Jafri NS Ann Intern Med 148 : 923 ~ 931 [2008]
  • Meta-analysis: is sequential therapy superior to standard triple therapy for Helicobacter pylori infection in Asian adults?
    Yoon H J Gastroenterol Hepatol 28 : 1801 ~ 1809 [2013]
  • Meta-analysis: four-drug, three-antibiotic, non-bismuth-containing 'concomitant therapy' versus triple therapy for Helicobacter pylori eradication
    Essa AS Helicobacter 14 : 109 ~ 118 [2009]
  • Meta-analysis: esomeprazole or rabeprazole vs. first-generation pump inhibitors in the treatment of Helicobacter pylori infection
    McNicholl AG Aliment Pharmacol Ther 36 : 414 ~ 425 [2012]
  • Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report
    Malfertheiner P Gut 61 : 646 ~ 664 [2012]
  • Institutional difference of antibiotic resistance of Helicobacter pylori strains in Korea
    Kim N J Clin Gastroenterol 40 : 683 ~ 687 [2006]
  • Importance of childhood socioeconomic status on the current prevalence of Helicobacter pylori infection
    Malaty HM Gut 35 : 742 ~ 745 [1994]
  • Helicobacter pylori 내성 증가에 따른 새로운 치료법
    신운건 대한내과학회지 85 (6) : 586 ~ 588 [2013]
  • Helicobacter pylori treatment in the era of increasing antibiotic resistance
    Graham DY Gut 59 : 1143 ~ 1153 [2010]
  • Helicobacter pylori infection: is sequential therapy superior to standard triple therapy? A single-centre Italian study in treatment-naive and non-treatment-naive patients
    Urgesi R Can J Gastroenterol 25 : 315 ~ 318 [2011]
  • Helicobacter pylori infection in hemodialysis patients: susceptibility to amoxicillin and clarithromycin
    Aydemir S World J Gastroenterol 11 : 842 ~ 845 [2005]
  • Helicobacter pylori infection in Japan
    Shiota S Expert Rev Gastroenterol Hepatol 7 : 35 ~ 40 [2013]
  • Helicobacter pylori infection and coronary heart disease in Japanese patients
    Osawa H Cardiology 95 : 14 ~ 19 [2001]
  • Helicobacter pylori infection
    McColl KE N Engl J Med 362 : 1597 ~ 1604 [2010]
  • Helicobacter pylori in Hispanics : comparison with blacks and whites of similar age and socioeconomic class
    Malaty HM Gastroenterology 103 : 813 ~ 816 [1992]
  • Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial
    Wong BC JAMA 291 : 187 ~ 194 [2004]
  • Helicobacter pylori eradication improves gastric atrophy and intestinal metaplasia in long-term observation
    Kodama M Digestion 85 : 126 ~ 130 [2012]
  • Helicobacter pylori and antimicrobial resistance: molecular mechanisms and clinical implications
    Gerrits MM Lancet Infect Dis 6 : 699 ~ 709 [2006]
  • H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer
    Gisbert JP Cochrane Database Syst Rev (2) : CD004062 ~ [2004]
  • Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition
    Asaka M. Helicobacter 15 : 1 ~ 20 [2010]
  • Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy
    Gatta L BMJ 347 : f4587 ~ [2013]
  • Global burden of cancers attributable to infections in 2008: a review and synthetic analysis
    de Martel C Lancet Oncol 13 : 607 ~ 615 [2012]
  • Geographical difference in antimicrobial resistance pattern of Helicobacter pylori clinical isolates from Indian patients: multicentric study
    Thyagarajan SP J Gastroenterol Hepatol 18 : 1373 ~ 1378 [2003]
  • Geographic map and evolution of primary Helicobacter pylori resistance to antibacterial agents
    Boyanova L Expert Rev Anti Infect Ther 8 : 59 ~ 70 [2010]
  • Genetics of response to proton pump inhibitor therapy: clinical implications
    Dickson EJ Am J Pharmacogenomics 3 : 303 ~ 315 [2003]
  • Frequency of Antibiotic Resistance in Helicobacter pylori Strains Isolated from the Northern Population of Iran
    Amin Talebi Bezmin Abadi The Journal of Microbiology 49 (6) : 987 ~ 993 [2011]
  • Fourth Chinese National Consensus Report on the management of Helicobacter pylori infection
    Liu WZ J Dig Dis 14 : 211 ~ 221 [2013]
  • Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality
    Ma JL J Natl Cancer Inst 104 : 488 ~ 492 [2012]
  • Factors affecting first-line triple therapy of Helicobacter pylori including CYP2C19 genotype and antibiotic resistance
    Lee JY Dig Dis Sci : 1 ~ 9 [2014]
  • Eradication of Helicobacter pylori according to 23S ribosomal RNA point mutations associated with clarithromycin resistance
    Lee HJ J Infect Dis 208 : 1123 ~ 1130 [2013]
  • Epidemiology of Helicobacter pylori infection in the Czech Republic
    Bures J Helicobacter 11 : 56 ~ 65 [2006]
  • Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status
    Graham DY Gastroenterology 100 : 1495 ~ 1501 [1991]
  • Empirical levofloxacin- containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial
    Romano M Gut 59 : 1465 ~ 1470 [2010]
  • Effects of CYP2C19 loss-of-function variants on the eradication of H. pylori infection in patients treated with proton pump inhibitor-based triple therapy regimens: a meta-analysis of randomized clinical trials
    Tang HL PLoS One 8 : 62162 ~ [2013]
  • Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study
    Graham DY Ann Intern Med 116 : 705 ~ 708 [1992]
  • Effect of the CYP2C19 polymorphism on the eradication rate of Helicobacter pylori infection by 7-day triple therapy with regular proton pump inhibitor dosage
    Kang JM J Gastroenterol Hepatol 23 : 1287 ~ 1291 [2008]
  • Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial
    Fukase K Lancet 372 : 392 ~ 397 [2008]
  • Effect of CYP2C19 genetic polymorphisms on the efficacy of proton pump inhibitor-based triple therapy for Helicobacter pylori eradication: a meta-analysis
    Zhao F Helicobacter 13 : 532 ~ 541 [2008]
  • Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease
    Wu CY Gastroenterology 137 : 1641 ~ 1648 [2009]
  • Dual-priming oligonucleotide- based multiplex PCR for the detection of Helicobacter pylori and determination of clarithromycin resistance with gastric biopsy specimens
    Woo HY Helicobacter 14 : 22 ~ 28 [2009]
  • Distribution of antibiotic MICs for Helicobacter pylori strains over a 16-year period in patients from Seoul, South Korea
    Kim JM Antimicrob Agents Chemother 48 : 4843 ~ 4847 [2004]
  • Current evidence of effects of Helicobacter pylori eradication on prevention of gastric cancer
    최일주 The Korean Journal of Internal Medicine 28 (5) : 525 ~ 537 [2013]
  • Current European concepts in the management of Helicobacter pylori infection
  • Concomitant, sequential, and hybrid therapy for H. pylori eradication: a pilot study
    Zullo A Clin Res Hepatol Gastroenterol 37 : 647 ~ 650 [2013]
  • Comparison of hybrid and sequential therapies for Helicobacter pylori eradication in Iran: a prospective randomized trial
    Sardarian H Helicobacter 18 : 129 ~ 134 [2013]
  • Comparative study of Helicobacter pylori eradication rates with 5-day quadruple 'concomitant' therapy and 7-day standard triple therapy
    Kim SY J Clin Gastroenterol 47 : 21 ~ 24 [2013]
  • Clinical trial: clarithromycin vs. levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradication
    Molina-Infante J Aliment Pharmacol Ther 31 : 1077 ~ 1084 [2010]
  • Clinical prevention of gastric cancer by Helicobacter pylori eradication therapy: a systematic review
    Ito M J Gastroenterol 44 : 365 ~ 371 [2009]
  • Changing antimicrobial susceptibility epidemiology of Helicobacter pylori strains in Japan between 2002 and 2005
    Kobayashi I J Clin Microbiol 45 : 4006 ~ 4010 [2007]
  • Change in antibiotic resistance of Helicobacter pylori strains and the effect of A2143G point mutation of 23S rRNA on the eradication of H. pylori in a single center of Korea
    Hwang TJ J Clin Gastroenterol 44 : 536 ~ 543 [2010]
  • Antimicrobial susceptibility pattern of Helicobacter pylori strains isolated from adult dyspeptic patients in Tikur Anbassa University Hospital, Addis Ababa, Ethiopia
    Asrat D Ethiop Med J 42 : 79 ~ 85 [2004]
  • Antimicrobial susceptibility of Helicobacter pylori strains isolated in Bangladesh
    Nahar S J Clin Microbiol 42 : 4856 ~ 4858 [2004]
  • Antimicrobial resistance incidence and risk factors among Helicobacter pylori-infected persons, United States
    Duck WM Emerg Infect Dis 10 : 1088 ~ 1094 [2004]
  • Antibiotic resistance of Helicobacter pylori isolated in the Southeast Coastal Region of China
    Su P Helicobacter 18 : 274 ~ 279 [2013]
  • Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea
    Kim JJ J Antimicrob Chemother 47 : 459 ~ 461 [2001]
  • American College of Gastroenterology guideline on the management of Helicobacter pylori infection
    Chey WD Am J Gastroenterol 102 : 1808 ~ 1825 [2007]
  • A systematic review of Helicobacter pylori eradication therapy--the impact of antimicrobial resistance on eradication rates
    Houben MH Aliment Pharmacol Ther 13 : 1047 ~ 1055 [1999]
  • A randomized study comparing levofloxacin, omeprazole, nitazoxanide, and doxycycline versus triple therapy for the eradication of Helicobacter pylori
    Basu PP Am J Gastroenterol 106 : 1970 ~ 1975 [2011]
  • A new highly effective short-term therapy schedule for Helicobacter pylori eradication
    Zullo A Aliment Pharmacol Ther 14 : 715 ~ 718 [2000]
  • A new approach for elimination of gastric cancer deaths in Japan
    Asaka M. Int J Cancer 132 : 1272 ~ 1276 [2013]